Charles S. Cox, Jr., M.D., specializes in treatment and research surrounding stem cell therapy for traumatic brain injury and related neurological injuries (hypoxic-ischemic encephalopathy, stroke, spinal cord injury). He has published results of the first acute, autologous cell therapy treatment in a Phase I study for traumatic brain injury in children. He is also researching the use of stem cell therapies for adult traumatic brain injury and cerebral palsy.
Previous Interview: http://bit.ly/q5kbrz
Dong Kim, M.D., specializes in intracranial aneurysms, brain tumors, arteriovenous malformations, skull base tumors, carotid disease, trigeminal neuralgia and Chiari malformations. His research centers on the origin, development and treatment of brain aneurysms, including identifying the genes that lead to an inherited risk for aneurysms; in using stem cells for the treatment of neurologic disease and spinal cord injury; and genetic changes in brain tumors.
Previous Interview: http://abc.tv/KgL3hI
Sean I. Savitz, M.D., specializes in the treatment and research of acute stroke. His research includes using autologous stem cells after acute stroke given intravenously and subacute stroke given by intra-carotid administration; using umbilical cord tissue-derived cells for acute ischemic stroke; and using tPA in patients who wake up with symptoms of stroke.
Previous Interview: http://bit.ly/n6DlV5
Rick A. Wetsel, Ph.D. is leading a research program on the use of human embryonic stem cells to develop a transplantable source of lung cells that could be used to treat lung diseases such as acute respiratory distress syndrome and emphysema. Wetsel's team also is using these cells for gene therapy for inherited genetic defects affecting the lungs including cystic fibrosis and surfactant protein deficiency.
Previous Interview: http://bit.ly/qx0wMK